273 related articles for article (PubMed ID: 21725988)
1. Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population.
Younossi ZM; Stepanova M
Hepatology; 2011 Oct; 54(4):1167-78. PubMed ID: 21725988
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.
Yue X; Black CL; O'Halloran A; Lu PJ; Williams WW; Nelson NP
Vaccine; 2018 Feb; 36(9):1183-1189. PubMed ID: 29395521
[TBL] [Abstract][Full Text] [Related]
4. Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?
Koenig A; Stepanova M; Felix S; Kalwaney S; Clement S; Younossi ZM
Liver Int; 2016 Aug; 36(8):1096-100. PubMed ID: 27187614
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
6. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for acute viral hepatitis--United States, 2006.
Wasley A; Grytdal S; Gallagher K;
MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.
Lu PJ; Byrd KK; Murphy TV; Weinbaum C
Vaccine; 2011 Sep; 29(40):7049-57. PubMed ID: 21782873
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
Chen H; Cantrell CR
Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
[TBL] [Abstract][Full Text] [Related]
11. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
Lau DT; Hewlett AT
Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
13. Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination.
Vogt TM; Wise ME; Bell BP; Finelli L
J Infect Dis; 2008 May; 197(9):1282-8. PubMed ID: 18422440
[TBL] [Abstract][Full Text] [Related]
14. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
Oldfield EC; Keeffe EB
Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
[TBL] [Abstract][Full Text] [Related]
15. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
Stepanova M; Rafiq N; Younossi ZM
Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis vaccination and infection among gay, bisexual, and other men who have sex with men who attend gyms in New York City.
Siconolfi DE; Halkitis PN; Rogers ME
Am J Mens Health; 2009 Jun; 3(2):141-9. PubMed ID: 19477727
[TBL] [Abstract][Full Text] [Related]
17. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
18. Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States.
Trantham L; Kurosky SK; Zhang D; Johnson KD
Vaccine; 2018 Aug; 36(35):5333-5339. PubMed ID: 29909136
[TBL] [Abstract][Full Text] [Related]
19. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
20. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
